Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up

Butler, A.C. and Tait, R.C. (1998) Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. British Journal of Haematology, 103(4), pp. 1064-1066. (doi: 10.1046/j.1365-2141.1998.01078.x) (PMID:9886320)

Full text not currently available from Enlighten.

Abstract

35 patients with oral anticoagulant (OAC) related intracranial or intraspinal haemorrhage were studied to determine treatment received, outcome and rate of recurrent bleeding and thromboembolism after restarting OAC. All patients underwent active anticoagulant reversal and in 14 patients with prosthetic heart valves (PHV) the INR remained below 2.0 for 0–19 d (median 7) with no thromboembolic events. 10 patients received heparin, although a therapeutic level was rarely achieved. 13 patients with PHV were restarted on OAC and followed for a median 23.5 months. One patient had recurrent intracranial bleeding. 3/13 patients had cerebral embolic events despite anticoagulation. We conclude that in PHV patients temporary cessation of OAC is safe and the risk of recurrent bleeding after restarting OAC is low.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Tait, Dr Robert
Authors: Butler, A.C., and Tait, R.C.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:British Journal of Haematology
Publisher:Blackwell Science
ISSN:0007-1048
ISSN (Online):1365-2141

University Staff: Request a correction | Enlighten Editors: Update this record